News Judge backs Lilly in Novo lawsuit over weight-loss drug ads A US judge has blocked Novo's request for an injunction on Eli Lilly's advertising for weight-loss and diabetes drugs Mounjaro and Zepbound.
News FTC says Shkreli is flouting lifetime pharma ban The FTC and several US states have accused Martin Shkreli of violating a lifetime order preventing him from involvement in the pharma industry.
News PhRMA sues Trump administration over GLOBE rebate scheme PhRMA is challenging the Trump administration's GLOBE model for Most-Favoured Nation pricing in Medicare Part B in a US district court.
News MSD ordered to pull injectable Keytruda from sale in Europe MSD has been rocked by a court judgment ordering it to stop making and selling subcutaneous Keytruda in eight European markets.
News Two men charged with infiltrating fake Ozempic into US Two Indian nationals are facing charges relating to the sale of counterfeit versions of Novo's diabetes treatment Ozempic to distributors in the US.
News Lilly sues over 'illegal sales' of obesity drug retatrutide Eli Lilly has sued six US-based companies it accuses of participating in an illegal black market for experimental weight-loss drug retatrutide.
News Astellas pays $285m for Audax cancer drug, and other deals Astellas takes an option on a cancer immunotherapy developed by Audax for up to $1.34bn, with Gilead and Teva also adding to their pipelines.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.